Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Optimization of trans-Resveratrol bioavailability for human therapy.

Amiot MJ, Romier B, Dao TM, Fanciullino R, Ciccolini J, Burcelin R, Pechere L, Emond C, Savouret JF, Seree E.

Biochimie. 2013 Jun;95(6):1233-8. doi: 10.1016/j.biochi.2013.01.008.

PMID:
23376875
3.

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL.

Cancer Chemother Pharmacol. 2011 Sep;68(3):593-601. doi: 10.1007/s00280-010-1525-4.

5.

Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation.

Vitaglione P, Ottanelli B, Milani S, Morisco F, Caporaso N, Fogliano V.

J Gastroenterol Hepatol. 2009 Apr;24(4):618-22. doi: 10.1111/j.1440-1746.2008.05598.x.

PMID:
18823437
6.

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.

Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP.

J Pharmacol Exp Ther. 2002 Jul;302(1):369-73.

7.

Bioavailability of trans-resveratrol from red wine in humans.

Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R.

Mol Nutr Food Res. 2005 May;49(5):495-504.

PMID:
15830336
8.

Pharmacokinetic study of trans-resveratrol in adult pigs.

Azorín-Ortuño M, Yañéz-Gascón MJ, Pallarés FJ, Vallejo F, Larrosa M, García-Conesa MT, Tomás-Barberán F, Espín JC.

J Agric Food Chem. 2010 Oct 27;58(20):11165-71. doi: 10.1021/jf102799m.

PMID:
20886884
9.
10.

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Markowitz JS, Straughn AB, Patrick KS, DeVane CL, Pestreich L, Lee J, Wang Y, Muniz R.

Clin Pharmacokinet. 2003;42(4):393-401.

PMID:
12648029
11.

Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

Poo JL, Galán JF, Rosete A, de Lago A, Oliva I, González-de la Parra M, Jiménez P, Burke-Fraga V, Namur S.

Clin Ther. 2008 Apr;30(4):693-9.

PMID:
18498918
12.

Inhibition of cancer growth by resveratrol is related to its low bioavailability.

Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E, Estrela JM.

Free Radic Biol Med. 2002 Aug 1;33(3):387-98.

PMID:
12126761
13.
14.

High absorption but very low bioavailability of oral resveratrol in humans.

Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK.

Drug Metab Dispos. 2004 Dec;32(12):1377-82.

15.

Effect of food on the pharmacokinetic profile of trans-resveratrol.

Vaz-da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-da-Silva P.

Int J Clin Pharmacol Ther. 2008 Nov;46(11):564-70.

PMID:
19000554
16.

Absorption of three wine-related polyphenols in three different matrices by healthy subjects.

Goldberg DM, Yan J, Soleas GJ.

Clin Biochem. 2003 Feb;36(1):79-87.

PMID:
12554065
17.

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.

Vitrac X, Desmoulière A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Mérillon JM.

Life Sci. 2003 Apr 4;72(20):2219-33.

PMID:
12628442
18.

Resveratrol nanoformulations: challenges and opportunities.

Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A.

Int J Pharm. 2015 Feb 20;479(2):282-90. doi: 10.1016/j.ijpharm.2015.01.003. Review.

PMID:
25572692
19.

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.

Clin Ther. 2007 Jun;29(6):1146-52.

PMID:
17692728
20.

Bioequivalence of two formulations of glucosamine sulfate 500-mg capsules in healthy male Chinese volunteers: an open-label, randomized-sequence, single-dose, fasting, two-way crossover study.

Zhu Y, Zou J, Xiao D, Fan H, Yu C, Zhang J, Yang J, Guo D.

Clin Ther. 2009 Jul;31(7):1551-8. doi: 10.1016/j.clinthera.2009.07.019.

PMID:
19695404
Items per page

Supplemental Content

Support Center